On January 14, Nancy Pelosi made a surprising investment in Tempus AI (NASDAQ: TEM) amounting to 50 call options with a ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tempus AI, Inc. ("Tempus" or "the Company") (NASDAQ: TEM) for violations of §§10 ...

In an exciting development for Tempus AI (NasdaqGS:TEM), the company experienced a significant 51% increase in its share price over the last quarter. This surge coincides with major events including ...

Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Tempus AI, Inc.

Tempus AI Inc. misled investors about the worth of its deals and artificial intelligence abilities, obscuring weaknesses with ...

Friday’s deal with CSPC fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in ...

The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, ...

Under Friday's agreement, the two companies will collaborate to discover and develop pre-clinical candidates, including a ...

Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise ...

TheStreet. While much of Wall Street is focused on AI chipmakers and cloud giants, one AI health care stock is quietly making ...